To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Histological remission in inflammatory bowel disease and female fertility: A nationwide study
Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden;; Department of Pediatrics, Queen Silvia Children's Hospital, Gothenburg, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Inflammatory Bowel Disease Center at NYU Langone Health, Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine, New York, New York. USA.
Show others and affiliations
2024 (English)In: Gastroenterology, ISSN 0016-5085, E-ISSN 1528-0012, Vol. 166, no 5, p. 802-814.e18Article in journal (Refereed) Published
Abstract [en]

BACKGROUND & AIMS: Inflammatory bowel disease (IBD) is linked to reduced female fertility, but it is unclear how fertility rates vary by histological disease activity.

METHODS: Nationwide IBD cohort of Swedish women aged 15-44 years. We examined fertility rates during periods with vs. without histological inflammation (n=21,046; follow-up: 1990-2016) and during periods with vs. without clinical activity (IBD-related hospitalization, surgery, or treatment escalation) (n=24,995; follow-up: 2006-2020). Accounting for socio-demographics and comorbidities, we used Poisson regression to estimate adjusted fertility rate ratios (aFRRs) for live-births conceived during 12-month-periods of histological inflammation (vs. histological remission) and 3-month-periods of clinically active IBD (vs. quiescent IBD).

RESULTS: During periods with vs. without histological inflammation, there were 6.35 (95%CI=5.98-6.73) and 7.09 (95%CI=6.48-7.70) live-births conceived per 100 person-years of follow-up, respectively, or one fewer child per fourteen women with 10 years of histological inflammation (aFRR=0.90; 95%CI=0.81-1.00). In women with histological inflammation fertility was similarly reduced in ulcerative colitis (UC, aFRR=0.89 [95%CI=0.78-1.02]) and Crohn's disease (CD, aFRR=0.86 [95%CI=0.72-1.04]). Clinical IBD activity was associated with an aFRR of 0.76 (95%CI=0.72-0.79) or one fewer child per six women with 10 years of clinical activity. Fertility was reduced in clinically active UC (aFRR=0.75 [95%CI=0.70-0.81]) and CD (aFRR=0.76 [95%CI=0.70-0.82]). Finally, also among women with clinically quiescent IBD, histological inflammation (vs. histological remission) was associated with reduced fertility (aFRR=0.85 [95%CI=0.73-0.98]).

CONCLUSIONS: An association between histological and clinical activity and reduced female fertility in CD and UC was found. Notably, histological inflammation was linked to reduced fertility also in women with clinically quiescent IBD.

Place, publisher, year, edition, pages
American Gastroenterology Association Institute , 2024. Vol. 166, no 5, p. 802-814.e18
Keywords [en]
Histology, Population-based, Remission
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-111491DOI: 10.1053/j.gastro.2024.01.018ISI: 001233482400001PubMedID: 38331202Scopus ID: 2-s2.0-85188431789OAI: oai:DiVA.org:oru-111491DiVA, id: diva2:1836494
Funder
Swedish Society for Medical Research (SSMF), S20-0007Swedish Research Council, 2020-01980; 2020-02002Swedish Society of Medicine, SLS-935346/935415/935418; SLS-789611Karolinska InstituteNIH (National Institutes of Health), K23DK124570Region Stockholm, 20170670
Note

Grant support: KM: ALF-funding from Region Västra Götaland, grants from the University of Gothenburg, Sweden, Birgitta och Göran Karlssons foundation, The Swedish Society for Medical Research (S20-0007), The Swedish Research Council (Dnr 2020-01980), The Swedish Society of Medicine (SLS-935346/935415/935418). JFL: Karolinska Institutet. OO: Swedish Research Council (Dnr: 2020-02002), The Swedish Society of Medicine (SLS-789611), ALF (20190638). JA: Crohn’s and Colitis Foundation, the Judith Stewart Colton Center for Autoimmunity, and the NIH NIDDK Diseases K23DK124570. GB: Stockholm Region clinical postdoctoral appointment (Dnr: 20170670).

Available from: 2024-02-09 Created: 2024-02-09 Last updated: 2025-02-11Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Halfvarson, JonasLudvigsson, Jonas F.

Search in DiVA

By author/editor
Halfvarson, JonasLudvigsson, Jonas F.
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Gastroenterology
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 26 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf